Bayforest Capital LTD Novavax Inc Transaction History
Bayforest Capital LTD
- $121 Billion
- Q1 2025
A detailed history of Bayforest Capital LTD transactions in Novavax Inc stock. As of the latest transaction made, Bayforest Capital LTD holds 62,983 shares of NVAX stock, worth $394,903. This represents 0.2% of its overall portfolio holdings.
Number of Shares
62,983Holding current value
$394,903% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
287Shares Held
93.3MCall Options Held
5.34MPut Options Held
8.7M-
Vanguard Group Inc Valley Forge, PA15.7MShares$98.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$74.3 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$69.9 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$48.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$36.3 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $490M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...